Pages that link to "Q24299360"
Jump to navigation
Jump to search
The following pages link to Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein (Q24299360):
Displaying 50 items.
- PML nuclear body scaffold (Q21106974) (← links)
- mitogen-activated protein kinase 7 (Q21156654) (← links)
- BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction (Q24295121) (← links)
- The function, regulation and therapeutic implications of the tumor suppressor protein, PML (Q26779358) (← links)
- The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy (Q26799596) (← links)
- MEK5/ERK5 pathway: the first fifteen years (Q26866383) (← links)
- ERK5 and Cell Proliferation: Nuclear Localization Is What Matters (Q28078572) (← links)
- Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex (Q28854310) (← links)
- KLF4 is a key determinant in the development and progression of cerebral cavernous malformations (Q30278010) (← links)
- An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection (Q30415276) (← links)
- Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer (Q33610918) (← links)
- A positive feedback loop involving Erk5 and Akt turns on mesangial cell proliferation in response to PDGF. (Q33701475) (← links)
- DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma (Q33788066) (← links)
- High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors (Q33975831) (← links)
- How chemoproteomics can enable drug discovery and development (Q34143272) (← links)
- When Signaling Kinases Meet Histones and Histone Modifiers in the Nucleus (Q34183219) (← links)
- Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors (Q34470378) (← links)
- ERK5 signalling in prostate cancer promotes an invasive phenotype (Q34627879) (← links)
- A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes (Q34774721) (← links)
- MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis (Q34946215) (← links)
- Therapeutic potential of ERK5 targeting in triple negative breast cancer (Q34956816) (← links)
- ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells. (Q35189239) (← links)
- Vesicular Stomatitis Virus Expressing Tumor Suppressor p53 Is a Highly Attenuated, Potent Oncolytic Agent (Q35275179) (← links)
- Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription (Q35562907) (← links)
- Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover (Q35639937) (← links)
- Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma (Q35651895) (← links)
- Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals? (Q35808644) (← links)
- BMK1 kinase suppresses epithelial-mesenchymal transition through the Akt/GSK3β signaling pathway (Q35836506) (← links)
- A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis (Q36080701) (← links)
- IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC. (Q36109355) (← links)
- Phosphorylation of BMK1 induces prostatic carcinoma cell proliferation by promoting entry into the S phase of the cell cycle (Q36502685) (← links)
- Post-translational modifications of PML: consequences and implications (Q36516772) (← links)
- Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L. (Q36545136) (← links)
- Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis (Q36781128) (← links)
- New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers (Q36850742) (← links)
- Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site (Q36862130) (← links)
- ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma. (Q36879241) (← links)
- ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation (Q36918817) (← links)
- E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis (Q37006778) (← links)
- ERK5 kinase activity is dispensable for cellular immune response and proliferation (Q37369392) (← links)
- Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones (Q37556126) (← links)
- Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice. (Q37688789) (← links)
- ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells (Q37724276) (← links)
- Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma (Q37741262) (← links)
- ERK5 and its role in tumour development (Q37977186) (← links)
- Regulation of the tumor suppressor PML by sequential post-translational modifications (Q38072052) (← links)
- PML tumour suppression and beyond: therapeutic implications (Q38189168) (← links)
- The role of ERK5 in endothelial cell function. (Q38268448) (← links)
- Profiling protein kinases and other ATP binding proteins in Arabidopsis using Acyl-ATP probes (Q38450704) (← links)
- Fluid shear stress promotes osteoblast proliferation via the Gαq-ERK5 signaling pathway (Q38775253) (← links)